Savient Pharmaceuticals (WKN 813149)

Fighting Chronic Problems: Savient’s CEO Explains
http://www.pharmalot.com/2012/10/...c-problems-savients-ceo-explains/


Ein Auszug (-das passt ja zur News vom Freitag!-):

...Pharmalot: Any other milestones coming up?
Ferrari: We’re expecting to hear back from the CHMP in Europe over the next couple of weeks on an opinion. That will be a milestone...


Wird wohl der nächste Schritt:

...Pharmalot: And how is the partnership hunt going?
Ferrari: We’re looking for a partner in Europe and the rest of the world. There are a number of companies that have expressed interest and we’re in active discussions. We don’t want to go it alone in Europe. It would have cost us $30 million or more to go forward in Europe at a time when we were battling on a lot of fronts. But right now, we have two years’ worth of cash. And we’re not under any pressure to raise any more. But we think any partnership ex-US will bring us some good revenues, including what we believe will bring upfront payments and royalties. Right now I think we’re in a pretty good spot...  

Sofort zu Beginn so ein Volumen und das ohne News?!  

Savient Pharmaceuticals Announces the Election of Genzyme CEO Dr. David Meeker to Its Board of Directors

http://finance.yahoo.com/news/...nces-election-genzyme-133000592.html


Savient's KRYSTEXXA® (pegloticase) Receives European Commission Marketing Authorization for the Treatment of Certain Patients with Chronic Tophaceous Gout

http://finance.yahoo.com/news/...ase-receives-european-164200776.html


GLTA
Bleibe dabei  

 bin heute mal eingestiegen vielleicht schafen wir ja bis 1 dollar marke  was denkt ihr???

 

Wie sieht's mit dem Eigenkapital aus?

Die produkt-Umsätze sind ja nicht gerade berauschend und decken nichtmal die kosten.

Wie lange wird das Cash noch reichen?